Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $5.5850 (9.4%) ($5.0500 - $5.6400) on Wed. May. 20, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.95% (three month average) | RSI | 70 | Latest Price | $5.5850(9.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 2.8% a day on average for past five trading days. | Weekly Trend | BCRX advances 15.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) IBB(9%) IWC(9%) IWM(9%) XHB(9%) IFRA(8%) | Factors Impacting BCRX price | BCRX will decline at least -4.975% in a week (0% probabilities). IGOV(-6%) TLT(-3%) VIXM(-2%) UUP(-2%) INDA(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.975% (StdDev 9.95%) | Hourly BBV | 1.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.2(7.4%) | 10 Day Moving Average | $5.06(10.38%) | 20 Day Moving Average | $4.39(27.22%) | To recent high | 0% | To recent low | 10% | Market Cap | $985m | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |